New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2014
11:54 EDTICPTIntercept rises 14% to $343.49 as trial link circulated
Shares of Intercept Pharmaceuticals (ICPT) are significantly higher in late morning trading, with the move up potentially related to the circulation of a link to data on a clinical trial being run by Intercept for its study to test Obeticholic Acid's effectiveness when used in patients with moderately severe alcoholic hepatitis. The trial was initially posted to the government's ClinicalTrials.gov website in January, though it is unclear if new data has been made available via the site or otherwise. Reference Link
News For ICPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
08:40 EDTICPTDeutsche Bank biotech analyst holds an analyst/industry conference call
Biotech Analyst Young provides a review of the ICPT/GNFT thesis on an Analyst/Industry conference call to be held on October 22 at 11 am.
06:43 EDTICPTNASH market big enough for multiple players, says Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use